{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:24Z","timestamp":1794651384514,"version":"4.9.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/pai.0b013e318257cc1c","type":"journal-article","created":{"date-parts":[[2012,5,16]],"date-time":"2012-05-16T12:54:47Z","timestamp":1337172887000},"page":"59-63","source":"Crossref","is-referenced-by-count":53,"title":["PAX8 Mouse Monoclonal Antibody [BC12] Recognizes a Restricted Epitope and Is Highly Sensitive in Renal Cell and Ovarian Cancers But Does Not Cross-react With B Cells and Tumors of Pancreatic Origin"],"prefix":"10.1097","volume":"21","author":[{"given":"David","family":"Tacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1440-1827.2006.01959.x","article-title":"Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors.","volume":"56","author":"Zhang","year":"2006","journal-title":"Pathol Int"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/modpathol.2009.88","article-title":"Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study.","volume":"22","author":"Tong","year":"2009","journal-title":"Mod Pathol"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors.","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R8-7-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study.","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/modpathol.2011.162","article-title":"N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas.","volume":"25","author":"Moretti","year":"2012","journal-title":"Mod Pathol"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R11-7-20210126","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/cncy.20136","article-title":"PAX8 is expressed in pancreatic well-differentiated neuroendocrine tumors and in extrapancreatic poorly differentiated neuroendocrine carcinomas in fine-needle aspiration biopsy specimens.","volume":"119","author":"Haynes","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"R12-7-20210126","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.2010.176","article-title":"PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.","volume":"24","author":"Sangoi","year":"2011","journal-title":"Mod Pathol"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00418-011-0866-3","article-title":"Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.","volume":"136","author":"Lorenzo","year":"2011","journal-title":"Histochem Cell Biol"},{"key":"R14-7-20210126","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R15-7-20210126","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/10520295.2011.591838","article-title":"Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.","volume":"87","author":"Ye","year":"2012","journal-title":"Biotech Histochem"},{"key":"R16-7-20210126","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/PAS.0b013e3181dc5e8a","article-title":"PAX8 ()p63 () immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.","volume":"34","author":"Albadine","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R17-7-20210126","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R18-7-20210126","first-page":"929","article-title":"Pax-QNRPax-6, a paired box- and homeobox-containing gene expressed in neurons, is also expressed in pancreatic endocrine cells.","volume":"8","author":"Turque","year":"1994","journal-title":"Mol Endocrinol"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00129039-201301000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:34:34Z","timestamp":1646235274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129039-201301000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0b013e318257cc1c","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}